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Acid-related gastric diseases are associated with disorder of digestive tract acidification. The 
gastric proton pump, H + ,K + -ATPase, exports H +  in exchange for luminal K +  to generate a 
highly acidic environment in the stomach, and is a main target for acid suppressants. Here, 
we report the three-dimensional structure of gastric H + ,K + -ATPase with bound SCH28080, a 
representative K + -competitive acid blocker, at 7 Å resolution based on electron crystallography 
of two-dimensional crystals. The density of the bound SCH28080 is found near transmembrane 
(TM) helices 4, 5 and 6, in the luminal cavity. The SCH28080-binding site is formed by 
the rearrangement of TM helices, which is in turn transmitted to the cytoplasmic domains, 
resulting in a luminal-open conformation. These results represent the first structural evidence 
for a binding site of an acid suppressant on H + ,K + -ATPase, and the conformational change 
induced by this class of drugs. 
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C
urrent therapies to treat gastric acid-related diseases such as 
peptic ulcer or gastroesophageal reflux disease either prevent 
the stimulation of parietal cells or inhibit the final step in 
acid production1. The former is accomplished by antagonizing his-
tamine H2 receptors, and the latter by targeting the gastric proton 
pump, H + ,K + -ATPase. Proton pump inhibitors (PPIs) such as ome-
prazole abolish enzyme activity by covalently binding to the C813 
residue of gastric H + ,K + -ATPase to alleviate the painful symptoms2. 
A new class of acid suppressants is undergoing clinical trials to pro-
vide a more rapid and efficient cure than achieved by PPIs. Unlike 
PPIs, SCH28080 (ref. 3) and its derivatives inhibit H + ,K + -ATPase 
noncovalently in a K + -competitive manner from the luminal side of 
the enzyme, and are thus called potassium-competitive acid block-
ers (P-CABs)4. As inhibition by omeprazole and SCH28080 is mutu-
ally exclusive5, the binding region of these two compounds seems 
to overlap.
H + ,K + -ATPase mediates the electro-neutral exchange of H +  and 
K +  across the parietal cell membrane accompanying ATP hydroly-
sis6. Characteristic of all P-type ATPases, vectorial cation transport 
is accomplished by cyclical conformational changes between the 
two principal reaction states (E1 and E2) and their corresponding 
phosphoenzyme intermediates (E1P and E2P), which are formed by 
reversible auto-phosphorylation of an aspartate residue in the invar-
iant  385DKTG motif7. According to the Post-Albers-type reaction 
scheme8, cytoplasmic-facing E1 and luminal-facing E2 states show 
high affinity for H +  and K + , respectively. H + ,K + -ATPase consists of 
two subunits. The catalytic α-subunit is homologous to the other 
P2-type ATPases9 such as Na + ,K + -ATPase and sarco(endo)plasmic 
reticulum  Ca2 + -ATPase  (SERCA).  It  comprises  ten  transmem-
brane (TM) helices (M1–M10), in which cation-binding sites are 
located,  and  three  cytoplasmic  domains,  the  nucleotide-binding 
(N), phosphorylation (P) and actuator (A) domains10. In addition 
to the α-subunit, H + ,K + - and Na + ,K + -ATPase require an accessory   
β-subunit, which is important for K + -occlusion11,12 and the func-
tional expression of the complex13. The H + ,K + -ATPase β-subunit is 
also important for blocking reversion of the transport cycle by stabi-
lizing the E2P conformation with its amino terminus14,15.
Despite the close similarity between the primary structures of 
the H + ,K + - and Na + ,K + -ATPase α-subunits (63% identity), their 
various specific inhibitors (such as SCH28080 for H + ,K + -ATPase or 
ouabain for Na + ,K + -ATPase) strictly discriminate their binding site 
in each target molecule. Yet, their inhibitory nature is quite similar,   
because  both  inhibitors  preferentially  bind  in  a  K + -competitive 
manner  to  the  extracellular  side  of  the  E2P  conformation3,16–18. 
Furthermore, some overlap between the binding sites is expected, 
because substitution of seven amino acids located in M4 and M5 
renders  H + ,K + -ATPase  ouabain-sensitive19.  The  recent  X-ray   
structure of Na + ,K + -ATPase with bound K +  and ouabain shows 
the inhibitor-binding site in detail20. Although the structure repre-
sents ouabain binding in the low-affinity mode due to antagonism 
between ouabain and K + , the authors predicted the conformational 
change required for the high-affinity ouabain binding based on the 
luminal-open conformation of the beryllium fluoride (BeF)-bound 
SERCA E2BeF structure21. Despite a number of biochemical2,22 and 
mutagenesis studies23–29 as well as computational approaches27–29 for 
the interaction between the H + ,K + -ATPase and its inhibitors, how-
ever, the detailed structural information has not been elucidated.
Here,  we  show  for  the  first  time  structural  evidence  for  the 
SCH28080-binding site of H + ,K + -ATPase and the conformational 
rearrangement induced by the binding of SCH28080, which is a 
P-CAB  prototype  currently  under  development.  The  binding  of 
SCH28080 to the E2P conformation cannot be explained by a sim-
ple ‘lock and key’ model, because the binding induces the widely 
opened  luminal  cavity  formed  in  the  TM  domain,  which  itself 
requires the conformational change of the whole enzyme including 
the cytoplasmic domains and connecting linkers. Conversely, as 
shown by crystal structures of SERCA in various reaction states21,30, 
the  phosphorylation/dephosphorylation-driven  rearrangement  of 
the  cytoplasmic  domains  induces  open–close  movements  of  the 
TM helices. Therefore, the overall conformational change required 
for formation of the luminal-open structure is conserved, at least 
among H + ,K + -ATPase and SERCA, and most likely such tightly 
coupled motion between two highly separated parts of the enzyme 
(that is, cytoplasmic domains and TM helices) provides a frame-
work for all of P-type ATPases.
Results
Three-dimensional  structure  of  SCH28080-bound  H + ,K + -
ATPase.  To  elucidate  the  inhibitor-binding  site  and  induced 
conformational  changes  of  H + ,K + -ATPase,  we  prepared  two-
dimensional (2D) crystals in the presence of the phosphate analogue 
BeF and SCH28080, a P-CAB prototype. Similar to the previously 
reported  BeF-bound  2D  crystals31,  large  tubular  crystals  were 
formed in the presence of SCH28080 (Supplementary Fig. S1a), 
and were analysed by electron crystallography using cryo-electron 
microscopy32 (Supplementary Fig. S1 and Supplementary Table S1). 
The final three-dimensional electron microscopic density map (EM 
density map) was calculated to 7 Å resolution (Fig. 1a, Supplementary 
Movie  S1).  Consistent  with  the  crystallization  conditions,  the 
overall structure of the present EM density map (Fig. 1a) shows 
characteristic features of the ADP-insensitive E2P conformation to 
which SCH28080 is preferentially bound (Supplementary Fig. S2)16. 
The BeF-bound phosphorylation site (Asp385) at the P domain is 
covered by the A domain, and the ADP-bound N domain is separated 
from the P domain, thus the bound phosphate analogue seems to 
be isolated from both ADP and the bulk solution (Supplementary 
Fig. S3). The structure is not identical, however, to that of previously 
reported  pseudo-E2P  states14,31  (as  both  the  aluminium  fluoride 
(AlF)-bound E2AlF and the BeF-bound E2BeF structures of H + ,K + -
ATPase are indistinguishable at the currently achieved resolution, 
they are abbreviated as E2P* unless otherwise stated). Therefore, the 
present structure is designated as an SCH28080-bound pseudo-E2P 
state, (SCH)E2BeF, which represents a conformation different from 
that of the inhibitor-free E2P* structures described later. Because 
of the similarity in their primary sequences, overall conformations, 
and representative reaction states (inhibitor-bound E2P state), we 
used  the  ouabain-bound  Na + ,K + -ATPase20  atomic  model  (PDB 
ID: 3A3Y) as a starting template for the homology model. The EM 
density map allowed us to determine the position of the individual 
helices in the TM domain, as well as in the cytoplasmic domains, 
and we successfully generated a homology model of H + ,K + -ATPase 
by fitting them into the EM density map as rigid bodies.
SCH28080-binding site. As predicted by earlier homology model-
ling of H + ,K + -ATPase25–29 together with mutagenesis studies, the 
density responsible for bound SCH28080 was found in the lumi-
nal  cavity  (Fig.  1b).  The  subtraction  map  (that  is,  [EM  density 
map] − [homology model], green mesh in Fig. 1b, Fig. 2a,b) clearly 
shows an excess density in the centre of the luminal cavity. The 
density is located near the luminal part of M4, M5 and M6 in the 
luminal ion entry path ~12 Å from the ion-binding site (Fig. 1c), 
consistent with the K + -competitive inhibition mode of SCH28080 
(refs 3, 17). The density is also predicted to be surrounded by several 
important amino acids26–28 for SCH28080 affinity, including F332, 
A335, Y799, L809 and C813 (Fig. 1b,c). Molecular docking simu-
lation of SCH28080 to the H + ,K + -ATPase homology model sug-
gested that its potential binding site is close to the observed density   
(Fig. 2a), consistent with many of the earlier studies described above.
Another density can be found near the putative K + -binding site 
(Fig. 2b, upper density). The density is too far, however, to be con-
tributed to amino acids important for SCH28080 binding2,28, such 
as A335 (12.3 Å, the distance between Cα carbon of this residue and ARTICLE     
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the centre of the density) or C813 (9.1 Å) compared with their close 
proximity to the proposed binding site (5.4 Å for both A335 and 
C813). Furthermore, many reported mutations can affect inhibitor 
affinity without affecting K +  affinity25,26,28,29, showing that the com-
petitive nature of the SCH28080 is due to mutual exclusion and not 
to direct overlap of the inhibitor and ion binding sites. Therefore, 
we conclude that the upper density in Figure 2b is unlikely to repre-
sent a bound SCH28080 molecule. It is notable that the lower den-
sity in Figure 2b does not cover the complete SCH28080 molecule. 
Because SCH28080 is a non-chiral molecule, disorder or rotation of 
one part of the molecule relative to the other might be responsible 
for insufficient determination of its density.
Rearrangement  of  TM  helices  induced  by  SCH28080  bind-
ing. Comparison between the E2P* and (SCH)E2BeF structures of 
H + ,K + -ATPase reveals that binding of SCH28080 induces the rear-
rangement of, mostly, the M1–M4 helices at the luminal side of   
the enzyme (Fig. 3). Although all TM helices are located in similar 
positions on the cytoplasmic side of the membrane (Supplementary 
Fig. S4a,b), M3 and M4 bend outwardly at the luminal membrane 
interface (Fig. 3a, Supplementary Fig. S4c). This difference, which 
is also observed in the ouabain-bound Na + ,K + -ATPase structure20, 
clears  space  at  the  luminal  cavity  to  create  the  binding  site  for 
SCH28080, where M4 locates in the H + ,K + -ATPase E2P* structure 
(Fig. 3a). At the same time, the helix bundle of M1 and M2 moves 
towards the cytoplasmic side along with an outwards movement of 
M4 (Fig. 3). As a consequence, M1 and M2 come closer and appar-
ently restrict the SCH28080-binding site (Fig. 3a), which is consist-
ent with the slow dissociation of SCH28080 (ref. 16), the fourfold 
lower affinity of L141C mutant located in M2 (ref. 28) (Fig. 1b,c), 
and the photoaffinity labelling between the M1–M2 segment and 
a SCH28080 derivative22. Such an inwards swinging motion of the 
M1–M2 bundle (Fig. 3a,b) has not been observed in the Na + ,K + -
ATPase  structure  with  bound  ouabain  in  the  low-affinity  mode   
(Supplementary Fig. S5), but has been predicted in the high-affinity 
ouabain-binding model based on the SERCA E2BeF structure20,21, 
which is consistent with the previously reported important contri-
bution of the M1–M2 segment to the high-affinity ouabain bind-
ing33. Therefore, the M1–M2 movement observed in the H + ,K + -
ATPase structure (Supplementary Fig. S5) seems to be commonly 
involved  in  the  formation  of  the  high-affinity  inhibitor-binding 
pocket on both closely related ATPases. Overall, this rearrangement 
of the TM helices of the H + ,K + -ATPase results in the luminal-open 
conformation, similar to that observed in the SERCA E2BeF struc-
ture21,30, which presumably allows for the release of bound Ca2 + .
Conformational change of the whole-enzyme strcuture. The con-
formational change observed in the TM region is transmitted to 
the cytoplasmic part of the enzyme, mostly by connecting linker 
between the A domain and M2 (A-M2 linker, Fig. 4a–c). Because 
of the observed movement of the M1–M2 bundle on SCH28080   
binding (Fig. 3b), the A-M2 linker forms an upright rod-like con-
formation separate from the P domain in the (SCH)E2BeF structure 
(Fig. 4b,c), which is in distinct contrast to its configuration in E2P* 
(Fig. 4a)14,31. It should be noted that the A-M2 linker is missing in this 
(SCH)E2BeF homology model (Fig. 4b,c, dashed line, F161–P175), 
because of the large difference between the EM density map and 
the starting template structure (ouabain-bound Na + ,K + -ATPase20). 
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Figure 1 | SCH28080-bound E2P structure of H + ,K + -ATPase analysed at 7 Å resolution. (a) overall structure of the H + ,K + -ATPase. The molecular surface 
represents the EM density map (contoured at 1σ) with a superimposed homology model of H + ,K + -ATPase (ribbon). Bound SCH28080 at the luminal cavity 
and ADP at the n domain are shown as red and purple spheres, respectively. The yellow–brown box indicates the approximate location of the lipid bilayer. 
Colour code: A domain, blue; P domain, green; n domain, yellow; TM domain, light blue (surface); β-subunit, red. Colour of the TM helices of the homology 
model gradually changes from M1 (blue) to M10 (red). As described in the text, the homology model does not contain the A-M2 linker (dotted line in blue). 
(b) SCH28080-binding site viewed from the luminal side (red arrow in a). The amino acids important for SCH28080 affinity are indicated as spheres (red, 
more than 10 times lower affinity; orange: 3–10 times lower, based on mutagenesis studies)20–28 to show their locations on the chain trace of the homology 
model (ribbon, colour codes as in a). Green mesh represents the excess density (that is, [EM density map (1σ, white surface)] − [homology model], see 
text for details), showing good fit with the predicted position of SCH28080 by the docking simulation (stick model, see also Fig. 2a and Discussion).  
(c) A cross-section of the TM region perpendicular to the membrane plane. The EM density map contoured at 1σ is shown as a white surface, and the 
sectional surface is shown in blue. Dotted spheres indicate K + -binding sites of the na + ,K + -ATPase20 to show the approximate location of the cation binding 
site on the H + ,K + -ATPase, yet these ions are not resolved in the present (SCH)E2BeF structure because of the limited resolution of the EM density map 
and K + -free conditions for the 2D crystallization. The M6 helix was omitted for clarity. Bound SCH28080 (red stick, position predicted by the docking 
simulation) is found at the centre of the luminal cavity, apparently blocking the K + -entry pathway from the luminal side of the membrane.ARTICLE
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Comparison  of  the  A-M2  linker  conformations  among  several 
known structures of other P2-type ATPases20,21,30, however, reveals 
that  it  can  assume  mainly  two  conformations  (Supplementary   
Fig. S6). The A-M2 linker is unwound in structures of the E2AlF 
conformation of the H + ,K + -ATPase and SERCA, and the E2MgF 
structure of Na + ,K + -ATPase with bound ouabain, but a continu-
ous α-helical conformation in SERCA E2BeF21, and the latter fits   
well  into  the  EM  density  map  of  H + ,K + -ATPase  (SCH)E2BeF   
(Supplementary Fig. S6). Thus, it is highly likely that this part of 
M2 continues as an α-helix beyond the cytoplasmic interface of 
the membrane. As the mutation of Q159 found at the cytoplasmic 
end of M2 has a fourfold lower affinity29 for SCH28080 despite its 
location on the opposite side of the membrane 35 Å away from the 
SCH28080-binding site (Fig. 4b,c), the conformational change of 
the A-M2 linker is important for the formation of the SCH28080-
binding site. As suggested by SERCA structures21, the α-helix for-
mation of the A-M2 linker may shorten the distance between the 
A domain and M2, inducing the observed location of the M1–M2 
helix bundle (Fig. 3). Therefore, also for the H + ,K + -ATPase, the   
A-M2 linker works as a determinant for the position of the M1–M2 
bundle (Supplementary Fig. S6), which is likely to be coupled with 
the outwards movement of the M3–M4 helices.
According to this SCH28080-induced conformational change in 
the A-M2 linker, the A domain is rotated ~20° around an axis per-
pendicular to the membrane plane (Fig. 4c,d, see also Supplemen-
tary Fig. S7), and the P domain is shifted along with the A domain 
(Fig. 4d, see discussion). These movements of cytoplasmic domains 
are also found in SERCA structures during the transition from the 
E2AlF to the E2BeF states21 (Supplementary Fig. S7). Consequently, 
the overall conformation of the H + ,K + -ATPase (SCH)E2BeF shows a 
conformation similar to SERCA E2BeF, including luminal-open TM 
helices, an α-helical structure of the A-M2 linker, and the arrange-
ment of cytoplasmic domains. Therefore, the conformational rear-
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Figure 2 | SCH28080-binding site. (a) Predicted binding mode of 
SCH28080 (blue stick with transparent surface rendering) to the 
homology model (spheres) determined by docking simulations. The green 
mesh shows the subtracted density and amino acids important for the 
SCH28080-binding are highlighted in red or orange (as shown in Fig. 1b). 
The calculated binding site of SCH28080 fits well into the homology model 
as well as the experimentally determined density (green mesh), supporting 
the reliability of the proposed SCH28080-binding site. (b) Comparison 
between SCH28080- (red stick) and ouabain (white stick)-binding sites. 
The ribbon models represent the homology model of H + ,K + -ATPase 
(SCH)E2BeF (colour as in Fig. 1a, positions for several important amino 
acids are marked in red or orange as in Fig. 1b) and the X-ray structure of 
ouabain-bound na + ,K + -ATPase (grey)20. Indicated in green (ball and stick 
representation) are side chains, which must be mutated for the formation 
of an ouabain-sensitive H + ,K + -ATPase19. White spheres represent bound 
K +  ions in the na + ,K + -ATPase structure. The overlap between these two 
specific inhibitors seems to be consistent with their similar modes of 
inhibition. In both figure panels, helices M1 and M2 were omitted for clarity.
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Figure 3 | Rearrangement of TM helices induced by SCH28080 binding. (a) Comparison of the TM helices between E2AlF and (SCH)E2BeF structures.  
A cross-section of the luminal TM region parallel to the membrane plane is viewed from the luminal side of the membrane. Mesh represents the EM 
density map (1σ) of (SCH)E2BeF, with homology models of (SCH)E2BeF (colour ribbons as in Fig. 1a) and E2AlF (grey ribbon)14 superimposed. A cross-
section parallel to the membrane plane displays the contour level at the indicated plane (colour gradually changes from blue (1σ) to red (5σ) as indicated 
in the figure). White arrows indicate the conformational change of M1–M4 induced by the SCH28080 binding (red stick as in Fig. 1b). The position of the 
slice is indicated as a red box in Supplementary Fig. S4. (b) A view of the M1–M4 region perpendicular to the membrane plane showing inwardly swinging 
movement of the M1–M2 helix bundle (blue ribbon) along with an outwards movement of M3–M4 (cyan ribbon) compared with the E2AlF homology 
model (grey ribbon). Dotted lines indicate the approximate position of the lipid bilayer.ARTICLE     
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rangement in the cytoplasmic region is tightly coupled with that in 
the TM domain, the latter of which is essential for the high-affinity 
binding of SCH28080 to the H + ,K + -ATPase (see also Discussion).
In  contrast  to  the  previously  reported  E2AlF  structure14,  the 
cytoplasmically  exposed  N-terminal  tail  of  the  β-subunit  (βNt) 
is detached from the P domain of the α-subunit in the (SCH)E2P 
BeF structure (Fig. 4d). The βNt in the E2AlF structure is in close   
proximity to the N-terminal part of the α-subunit (αNt), which 
is completely absent in the (SCH)E2BeF presumably because of its 
disorder (Fig. 4d). Because the αNt structure contributes crystal 
contacts with a neighbouring molecule in the E2AlF structure in 
contrast to the present (SCH)E2BeF structure, its disorder might be 
related to the inherent flexibility of the αNt. The spatial proximity 
between the N-termini of the α- and β-subunits, however, suggests 
that the αNt is involved in the regulation of the unique inter-subu-
nit interaction between the βNt and the P domain.
Discussion
The predicted orientation of SCH28080 from the docking simula-
tion highly overlaps with the experimental density (Fig. 1b), thus 
further supporting the reliability of the proposed binding site. In 
the predicted binding model (Fig. 2a), the SCH28080 molecule is 
tightly  coordinated  by  several  important  amino  acids,  including 
F332 (ref. 28), A335 (ref. 28), Y799 (ref. 27), L809 (ref. 26), C813 
(covalent-binding site of PPIs)2,26, and L141 (not shown in Fig. 2a)29  
and  V338  (ref.  28),  I816  (ref.  26).  The  tight  binding  mode  of 
SCH28080 seems to be consistent with its high-affinity binding. 
This  SCH28080-binding  site  on  H + ,K + -ATPase  largely  overlaps 
with  the  ouabain-binding  site  on  Na + ,K + -ATPase20  (Fig.  2b),  in 
agreement with their similar mode of inhibition, and the position of 
seven amino acids, which must be mutated to generate a ouabain-
sensitive H + ,K + -ATPase (Fig. 2b)19, supporting the reliability of the 
proposed SCH28080-binding site. It should be noted that we used 
the homology model with a truncated luminal loop between M1 
and M2 (S129–D136) for the final molecular docking simulation. 
When we performed molecular docking using a ‘full-length’ homo-
logy model, the binding site shifted towards the M1–M2 loop com-
pared with the ‘final’ model. That shifted binding site is inconsistent 
with our EM density map as well as earlier mutation studies, and 
was thus rejected as a binding site. As the M1–M2 loop is invisible 
in the present EM density map (Fig. 1b), this part may be disordered 
and presumably does not contribute to SCH28080 binding, as sug-
gested by a previous study using chimeric enzymes between H + ,K +  
and Na + ,K + -ATPase24.
Structural comparison between the SCH28080-bound H + ,K + -
ATPase and the ouabain-bound Na + ,K + -ATPase20 reveals impor-
tant similarities and differences in the arrangement of their TM 
helices (Supplementary Fig. S5). Highly overlapped position of each 
inhibitor bound to M4 interface suggests that the outwards move-
ment of the M3–M4 bundle relative to their location in the E2P* 
conformation (Fig. 3a) is the primary event for the inhibitor binding 
on each closely related ATPase. There was, however, a significant 
difference in the orientation of the M1–M2 bundle (white arrows 
in Supplementary Fig. S5), in contrast to the similar arrangement 
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Figure 4 | SCH28080-induced conformational changes at the 
cytoplasmic part of the H + ,K + -ATPase. (a–c) Close-up view of the A-
M2 linker in E2AlF (a), (SCH)E2BeF (b) and their comparison (c). Each 
surface (white for E2AlF, blue for (SCH)E2BeF) and ribbon model (grey for 
E2AlF, colour for (SCH)E2BeF is as in Fig. 1a) represents the EM density 
map and homology model of the corresponding structures, respectively. 
The magenta sphere indicates Q159, which on mutation to Asn showed 
fourfold lower affinity for SCH28080. The A-M2 linker of E2AlF or 
(SCH)E2BeF is indicated by orange or blue arrows, respectively, yet the 
(SCH)E2BeF homology model does not contain this part (dotted blue 
line in b, c, see also text). note that density for the n-terminal domain 
of the α-subunit (αnt) is absent in the (SCH)E2BeF structure (b, dotted 
circle) in contrast to the E2AlF structure (a). (d) Conformational change 
of the cytoplasmic domains. The surface shows the EM density map of 
(SCH)E2BeF with its homology model superimposed (colour codes as in 
Fig. 1a: A domain, blue; P domain, green; n domain, yellow; TM domain, 
light blue). orange mesh represents the E2AlF EM density map. It should 
be noted that the inter-subunit interaction between the P domain and the 
n-terminal tail of the β-subunit (βnt) observed in the E2AlF structure is 
not present in the (SCH)E2BeF structure (arrowhead, see text for details). 
All the EM density maps are drawn with a 1σ contour level. White arrows 
in all panels indicate observed conformational changes during the E2AlF→
(SCH)E2BeF transition.ARTICLE
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of other TM helices. The observed orientation of M1–M2 bundle 
close to bound SCH28080 in H + ,K + -ATPase EM structure seems 
to accommodate the bound SCH28080 molecule, thus contributing 
to its high-affinity binding. This observation further supports the 
prediction for the high-affinity ouabain-binding mode of Na + ,K + -
ATPase20. Although the bound SCH28080 is apparently accessible 
from the luminal bulk solution (Fig. 1b), it is likely to be tightly 
coordinated in its binding cavity (Fig. 2). Therefore, such an open–
close movement of the M1–M2 bundle (Supplementary Fig. S5) as 
well as M3–M4 (Fig. 3a), during thermal fluctuation of the enzyme 
seems to be important for deep introduction of the inhibitor in its 
binding pocket, and for locking it in the appropriate position.
As described in the results section, SCH28080 binding induces 
a luminal-open conformation of H + ,K + -ATPase. The overall con-
formation of H + ,K + -ATPase (SCH)E2BeF is thus similar to that of 
SERCA E2BeF (refs 20, 21), in which the luminal ion gate is widely 
opened to release Ca2 + . Therefore, the observed luminal-open fea-
ture of H + ,K + -ATPase (SCH)E2BeF is suggestive for the exchange 
of transporting H + /K +  at the luminal side of the membrane, as the 
translocation of the cations, at least K + , requires physical paths to 
their binding site in H + ,K + -ATPase. As previously demonstrated, 
even using BeF alone, the H + ,K + -ATPase E2BeF structure shows 
the luminal-closed conformation31 in contrast to the Ca2 + -releas-
ing luminal-open conformation of SERCA E2BeF. Accordingly, in 
the case of H + ,K + -ATPase, the luminal-closed conformation found 
in E2P* structure seems to be energetically more favourable than 
the present luminal-open conformation, which is constrained by 
SCH28080 binding. Therefore, we speculate that the luminal-open 
conformation without SCH28080 can be formed, but is short-lived, 
transiently appearing during thermal fluctuation when cations are 
exchanged at the luminal side of the membrane.
Considering the K + -competitive nature of SCH28080 (refs 3, 
16, 17) and its structural feature described above, it is likely that 
the present structure partially reflects a K + -binding event, which 
significantly accelerates the dephosphorylation of E2P to proceed 
with the transport cycle. In addition, the inter-subunit interaction 
between βNt and the P domain in the E2AlF structure has been 
proposed  to  function  as  a  ‘ratchet’  to  prevent  a  physiologically 
  unfavourable reverse reaction (namely, E1P formation from E2P) by 
tethering the P domain in suitable position for the E2P formation14, 
thus stabilizing the E2P conformation15. Therefore, the disruption 
of the inter-subunit interaction between the βNt and the P domain 
observed here might occur when the reaction cycle proceeds in the 
forwards direction from E2P. Further structural and functional ana-
lyses of different reaction intermediates (that is, K + -bound E2P or 
K + -occluded E2) are required, however, for a better understanding 
of the βNt function. Such conformational preference may be advan-
tageous for the prevention of the H +  reverse flow in the highly acidic 
environment of the stomach lumen.
Methods
Two-dimensional crystallization and image analysis. H + ,K + -ATPase-containing  
membrane fraction purified from pig stomach34,35 (8 mg ml − 1 of protein) was 
  solubilized for 10 min on ice with 6.5 mg ml − 1 octaethyleneglycol dodecylether (C12E8, 
Nikko Chemical) in 40 mM MES, 20 mM Mg(CH3COO)2, 5 mM ATP, 10% (v/v)  
glycerol and 3 mM dithiothreitol (DTT), at pH 5.5 adjusted by Tris buffer. The insolu-
ble material was removed by ultracentrifugation at 186,000 g for 20 min, and the super-
natant was mixed with dioleoylphosphatidylcholine (Avanti) at a lipid-to-protein ratio 
(w/w) ranging from 0.95 to 1.15. The samples were then placed in 10 µl microdialysis 
buttons (Hampton Research) using a dialysis membrane with a molecular weight 
cut-off of 25 kDa (SPECTRA/Pro #7, SPECTRUM), and first dialysed on ice for 36 h 
against 10 mM MES, 10% (v/v) glycerol, 10 mM MgCl2, 1 mM BeSO4, 4 mM NaF, 1 mM 
ADP, 3 mM DTT and 1 µM SCH28080 at pH 5.5 adjusted by Tris buffer, and then at 
3 °C for 12–16 days against 20 mM propionate, 1 mM MgCl2, 1 mM BeSO4, 4 mM  
NaF, 1 mM ADP, 3 mM DTT and 0.1 mM SCH28080, pH 4.8 adjusted by Tris buffer.
Samples were negatively stained with 2% (w/v) uranyl acetate to screen for 
crystallization conditions. Sample preparations for cryo-electron microscopy and 
image processing were as described previously31. Briefly, specimens were prepared 
in the cold room using the carbon sandwich method36. Images were recorded with 
a JEM-3000SFF electron microscope (JEOL) equipped with a super fluid helium 
stage32,37 on SO-163 film (Kodak). Digitized images were processed with the MRC 
image processing programme38 and their initial contrast transfer function param-
eters were determined39 for correction. The data tilted to 60° were merged using 
LATLINE40 and used to calculate a three-dimensional density map at 7 Å resolution 
(Supplementary Table S1).
Homology modelling and structural analysis. The homology model for the 
H + ,K + -ATPase (SCH)E2BeF structure was built with MODELLER v9.7 (ref. 41) 
using the atomic model of ouabain-bound Na + ,K + -ATPase20 (PDB code 3A3Y) as a 
starting template. The initial manual fitting of the homology model into the density 
map was achieved using the programme O42. The adjustment for each individual 
domain and TM helix with the EM density map was performed using SITUS43. 
After the positional search, further fine fitting and connecting the split loop region 
were performed manually using O or COOT44 with regularization refinement. 
The resulting homology model was consistent with the EM density map (Fig. 1a), 
except in the N-terminal domain and the A-M2 linker of the α-subunit, and in the 
β-subunit N-terminus and the ectodomain of the β-subunit; these regions were 
not included in the homology model for the following reasons: (i) The N-terminal 
domain of the α-subunit was invisible in the EM density map. (ii) The conforma-
tion of the A-M2 linker of the EM density map was very different from that in the 
starting template structure (Fig. 4, see also Supplementary Fig. S6 and text).  
(iii) The N-terminal tail of the β-subunit was not modelled because of its disorder 
in the X-ray structures of Na + ,K + -ATPase, in contrast to its strong appearance in 
the H + ,K + -ATPase EM density map. (iv) The overall structure of the β-subunit 
ectodomain seemed to be different between the EM density map of the H + ,K + -
ATPse and the X-ray structure of the Na + ,K + -ATPase, thus only overlapping parts 
are shown in the homology model.
To determine the SCH28080-binding site clearly, we generated the subtracted 
density map as follows. Subtraction of the estimated protein density from the EM 
density map (Fig. 1b and 2) was performed using UCSF Chimera45. The volume 
responsible for the protein part was defined as a 4 Å radius from the backbone 
chain tracing of the homology model. The whole EM density map, contoured at 
1σ, was then subtracted by this assumed protein volume in real space to show the 
surplus densities. As a result, one significant density is found at the centre of the 
luminal cavity, corresponding to the bound SCH28080 molecule as described in 
the results (green mesh in Figs 1b and 2).
The docking simulation of the SCH28080 was performed using AutoDock 
Vina46. Previous biochemical and mutagenesis studies22–29 suggest that the 
SCH28080-binding site is located in the cavity facing the gastric lumen. Therefore, 
the binding search was performed only for the luminal vestibule region (boxed 
region of 26 Å (x) × 20 Å (y) × 24 Å (z), with C813 centreing). The AUTODOCK 
Vina programme predicted several binding modes. All of the predicted binding 
sites were in the luminal cavity, surrounded by A335, Y799 and C813, but with 
different conformations of SCH28080 binding. Among them, the proposed binding 
mode had the highest score in this programme and the best fit to the EM density 
map. See also the Discussion for details. Figures were prepared using UCSF  
Chimera or Pymol (http://pymol.sourceforge.net/). 
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